New York City will pay the federal government more than $1 million to settle a whistleblower claim alleging fraud by the city’s schools.
The $1.375-million settlement, announced Monday, resolves allegations that the New York Education Department submitted false claims for Medicaid services not provided to special-education students.
For the full press release, please see:
http://www.justice.gov/opa/pr/2014/January/14-civ-037.html
Allergan Inc. paid kickbacks to induce prescriptions of the pharmaceutical company’s eye care drugs, according to allegations raised in a lawsuit unsealed on December 17, 2013 in federal court in Philadelphia. The lawsuit alleges that Allergan provided illegal inducements to eye care professionals throughout the United States, including business consulting services through its team of Eye Care Business Advisors,
On December 30, 2013, the United States District Court for the Western District of North Carolina, in response to a Department of Justice motion, unsealed a whistleblower lawsuit filed by North Carolina Emergency Room Physicians against Health Management Associates and Emergency Medical Services Corporation (“EmCare”). The “qui tam” whistleblower lawsuit was filed in Charlotte,
The Department of Justice announced that fiscal year 2013 was a record year for recovery of taxpayer dollars under the False Claims Act (“FCA”) with $3.8 billion obtained in settlements and judgments from FCA defendants. This recovery, the second largest in history, brings the total amount recovered under the Act since January 2009 to $17 billion.
Northrop Grumman, one of the nation’s largest defense contractors, agreed to pay $11.4 million to resolve allegations that it violated the Federal Acquisition Regulations (“FAR”) and the FCA. According to the allegations, Northrop failed to comply with its 2002 settlement agreement with the Defense Contract Management Agency (“DMCA”) by charging deferred compensation awards to key employees to its federal contracts,
The government’s recent massive settlement with Johnson & Johnson is paying dividends for the residents of Washington, D.C.
The District of Columbia’s Medicaid program will receive more than $3 million out of the $1.2 billion settlement, which resolved four qui tam cases filed in federal court in the Eastern District of Pennsylvania.
In early June, two Pennsylvania State legislators introduced House Bill 1493, a state version of the federal False Claims Act. The bill would reportedly provide the state with a crucial tool in fighting healthcare waste, fraud, and abuse.
“Pennsylvanians lose as much as $200 million a year through Medicare and Medicaid fraud and abuse,” said Democratic State Rep.
The decision by the District Court for the Southern District of New York to disqualify Fair Laboratory Practices Associates (FLPA) from its qui tam suit against Quest Diagnostics (Quest) and Unilab Corporation (Unilab) was recently affirmed by the US Court of Appeals for the Second Circuit. Unilab’s former general counsel,
Marc S. Raspanti will be presenting at an American Law Institute Webinar CLE on November 7, 2013. He will present on “Litigating a False Claims Act Whistleblower Case.”
For more information and to register for this presentation, please see:
http://www.ali-cle.org/index.cfm?fuseaction=courses.course&course_code=VCVI1107
If you are aware of any person, corporation or entity that you think may be violating the False Claims Act, securities, commodities, tax, anti-money laundering, or sanctions laws, contact us today.